Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LORAZEPAM vs LOTILANER: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LORAZEPAM vs LOTILANER: Safety Overview

Metric LORAZEPAM LOTILANER
Total FAERS Reports 33,404 1,622
Deaths Reported 6,187 15
Death Rate 18.5% 0.9%
Hospitalizations 15,431 27
Average Patient Age 49.8 yrs 65.2 yrs
% Female Patients 60.8% 67.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Jul 24, 2023
Manufacturer Hikma Pharmaceuticals USA Inc. Tarsus Pharmaceuticals, Inc.
Route INTRAMUSCULAR OPHTHALMIC
Marketing Status Prescription Prescription